Serina Therapeutics Inc – NYSE:SER

Serina Therapeutics stock price today

$5.01
-0.62
-11.17%
Financial Health
0
1
2
3
4
5
6
7
8
9

Serina Therapeutics stock price monthly change

-36.84%
month

Serina Therapeutics stock price quarterly change

-36.84%
quarter

Serina Therapeutics key metrics

Market Cap
53.30M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-19.43
Revenue
137K
EBITDA
-10M
Income
-20.96M
Revenue Q/Q
-50%
Revenue Y/Y
251.28%
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
-7299.27%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Serina Therapeutics stock price history

Serina Therapeutics stock forecast

Serina Therapeutics financial statements

Serina Therapeutics Inc (NYSE:SER): Profit margin
Jun 2023 9K -2.66M -29655.56%
Sep 2023 67K -5.40M -8061.19%
Dec 2023 56K -3.45M -6171.43%
Mar 2024 5K -9.43M -188740%
Serina Therapeutics Inc (NYSE:SER): Debt to assets
Jun 2023 9738696 45.02M 462.33%
Sep 2023 12210000 3.89M 31.92%
Dec 2023 11965000 6.60M 55.22%
Mar 2024 10856000 15.16M 139.69%
Serina Therapeutics Inc (NYSE:SER): Cash Flow
Jun 2023 -2.01M -315.34K 2M
Sep 2023 -1.86M 0 2M
Dec 2023 -2.05M 0 2M
Mar 2024 -1.57M -14K 2.72M

Serina Therapeutics alternative data

Serina Therapeutics Inc (NYSE:SER): Employee count
Jul 2024 9

Serina Therapeutics other data

Serina Therapeutics Inc (NYSE:SER): Insider trades (number of shares)
Period Buy Sel
May 2024 29357 0
Jun 2024 7600 0
Aug 2024 36319 0
Sep 2024 21525 0
Dec 2024 3866 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
BAILEY GREGORY director
Common Stock 3,866 $4.59 $17,745
Purchase
BAILEY GREGORY director
Common Stock 1,137 $6.03 $6,852
Purchase
BAILEY GREGORY director
Common Stock 11,679 $6.11 $71,382
Purchase
BAILEY GREGORY director
Common Stock 2,709 $6.23 $16,874
Purchase
MINTZ STEVEN director
Common Stock 6,000 $6.47 $38,814
Purchase
BAILEY GREGORY director
Common Stock 1,776 $8.25 $14,652
Purchase
BAILEY GREGORY director
Common Stock 6,400 $7.93 $50,758
Purchase
BAILEY GREGORY director
Common Stock 6,400 $7.31 $46,778
Purchase
BAILEY GREGORY director
Common Stock 6,400 $6.65 $42,579
Purchase
MINTZ STEVEN director
Common Stock 1,350 $6.59 $8,895
Monday, 16 December 2024
globenewswire.com
Wednesday, 11 December 2024
globenewswire.com
Monday, 2 December 2024
globenewswire.com
Tuesday, 12 November 2024
globenewswire.com
Monday, 11 November 2024
globenewswire.com
Wednesday, 4 September 2024
globenewswire.com
Friday, 9 August 2024
globenewswire.com
Monday, 29 July 2024
globenewswire.com
Thursday, 18 July 2024
globenewswire.com
Tuesday, 14 May 2024
globenewswire.com
  • What's the price of Serina Therapeutics stock today?

    One share of Serina Therapeutics stock can currently be purchased for approximately $5.01.

  • When is Serina Therapeutics's next earnings date?

    Serina Therapeutics Inc is estimated to report earnings on Monday, 4 Aug 2025.

  • Does Serina Therapeutics pay dividends?

    No, Serina Therapeutics does not pay dividends.

  • How much money does Serina Therapeutics make?

    Serina Therapeutics has a market capitalization of 53.30M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 71.6% to 142K US dollars.

  • What is Serina Therapeutics's stock symbol?

    Serina Therapeutics Inc is traded on the NYSE under the ticker symbol "SER".

  • How do i buy shares of Serina Therapeutics?

    Shares of Serina Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Serina Therapeutics have?

    As Jul 2024, Serina Therapeutics employs 9 workers.

  • When Serina Therapeutics went public?

    Serina Therapeutics Inc is publicly traded company for more then 25 years since IPO on 21 Jan 2000.

Serina Therapeutics company profile:

Serina Therapeutics Inc

Exchange:

NYSE

Full time employees:

9

Industry:

Sector:


,

:
ISIN: US81751A1088
: